

HY-15313 · 50 mg
MedChemExpress · Cat: HY-15313
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/cbb1007.html
Description
CBB1007 is a reversible and selective LSD1 inhibitor with an IC50 of 5.27 AAasAasAAmuM for human LSD1. CBB1007 significantly blocks the demethylase activity of LSD1 on H3K4Me2 and H3K4Me. CBB1007 shows selectivity for LSD1 over LSD2 or JARID1A, and induces differentiation-related genes in pluripotent cells. CBB1007 is studied in non-pluripotent cancer research, targeting teratocarcinoma, embryonic carcinoma, and seminoma.

